ABSTRACT
Most of the members of genus Brachystlema are found to be ‘rare, vulnerable and critically endangered’, and hence they have proven difficult to find in nature. This review aims to present the available data on in vitro propagation studies for conservation of these red-listed taxa and to explore their pharmacognostic, phytochemical, and pharmacological properties. Until now, limited research was done on this genus. Only a few reports were available on pharmacognostic, phytochemical, pharmacological, and on in vitro conservation of species of Brachystelma. The presence of phenolic and flavonoid compounds supports the antioxidant potential of these ethanomedicinal plants. Protocols for in vitro flowering and tuberization were also reviewed, along with micropropagation in these vulnerable plants. This review aims to provide sufficient baseline information to carry out further research for effective propagation of endangered species of this genus.
